业务
货币单位:美元
2024/Q3
名称营收比例
Human immunodeficiency virus (HIV)1,834.7万45.97%
Molecular Sample Management Solutions1,280.6万32.08%
Hepatitis C virus (HCV)322.8万8.09%
Coronavirus disease 2019 (COVID-19)215.5万5.40%
Risk assessment testing191.1万4.79%
Other product and service revenues119.6万3.00%
Non-product and services revenues26.3万0.66%
Molecular Services9,0000.02%
查看全部
地区
货币单位:美元
2023/FY
名称营收比例
美国3.62亿89.19%
其他地区3,570.1万8.80%
欧洲811.1万2.00%
